|
MechanismTubulin inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with AXLR, SATT Occitanie Méditerranée SAS
0 Patents (Medical) associated with AXLR, SATT Occitanie Méditerranée SAS
100 Deals associated with AXLR, SATT Occitanie Méditerranée SAS
100 Translational Medicine associated with AXLR, SATT Occitanie Méditerranée SAS